UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Zukunft Bildungschancen: Ergebnisse und Perspektiven aus Forschung und Praxis

2023

Volltextzugriff (PDF)

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update

Clinical pharmacology and therapeutics, 2022-11, Vol.112 (5), p.959-967

2022

Volltextzugriff (PDF)

Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine

Expert opinion on drug metabolism & toxicology, 2018-04, Vol.14 (4), p.447-460

2018

Volltextzugriff (PDF)

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing

Clinical pharmacology and therapeutics, 2021-06, Vol.109 (6), p.1417-1423

2021

Volltextzugriff (PDF)

CYP2D6 pharmacogenetics and phenoconversion in personalized medicine

Expert opinion on drug metabolism & toxicology, 2022-11, Vol.18 (11), p.769-785

2022

Volltextzugriff (PDF)

Pharmacogenetics in clinical practice: how far have we come and where are we going?

Pharmacogenomics, 2013-05, Vol.14 (7), p.835-843

Johnson, Julie A

2013

Volltextzugriff (PDF)

CYP2C19 Polymorphisms and Therapeutic Drug Monitoring of Voriconazole: Are We Ready for Clinical Implementation of Pharmacogenomics?

Pharmacotherapy, 2014-07, Vol.34 (7), p.703-718

2014

Volltextzugriff (PDF)

Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects

Metabolism, clinical and experimental, 2012-05, Vol.61 (5), p.641-651

2012

Volltextzugriff (PDF)

Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement

Blood, 2008-08, Vol.112 (4), p.1013-1021

2008

Volltextzugriff (PDF)

Individualized Placement and Support Supported Employment for Justice-involved Homeless and Unemployed Veterans

Medical care, 2021-04, Vol.59 (Suppl 2), p.S195-S198

2021

Volltextzugriff (PDF)

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

Blood, 2010-05, Vol.115 (18), p.3827-3834

2010

Volltextzugriff (PDF)

Comparison of Data Normalization Strategies for Array-Based MicroRNA Profiling Experiments and Identification and Validation of Circulating MicroRNAs as Endogenous Controls in Hypertension

Frontiers in genetics, 2022-03, Vol.13, p.836636-836636

2022

Volltextzugriff (PDF)

Clinical pharmacogenetics implementation: Approaches, successes, and challenges

American journal of medical genetics. Part C, Seminars in medical genetics, 2014-03, Vol.166C (1), p.56-67

2014

Volltextzugriff (PDF)

Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention

Journal of translational medicine, 2018-04, Vol.16 (1), p.92-92, Article 92

2018

Volltextzugriff (PDF)

CYP4F2 genetic variant alters required warfarin dose

Blood, 2008-04, Vol.111 (8), p.4106-4112

2008

Volltextzugriff (PDF)

Ethnic Differences in Cardiovascular Drug Response : Potential Contribution of Pharmacogenetics

Circulation (New York, N.Y.), 2008-09, Vol.118 (13), p.1383-1393

JOHNSON, Julie A

2008

Volltextzugriff (PDF)

A novel simple method for determining CYP2D6 gene copy number and identifying allele(s) with duplication/multiplication

PloS one, 2015-01, Vol.10 (1), p.e0113808

2015

Volltextzugriff (PDF)

Institutional profile: University of Florida Health Personalized Medicine Program

Pharmacogenomics, 2017-04, Vol.18 (5), p.421-426

2017

Volltextzugriff (PDF)

Circulating microRNA Biomarkers of Thiazide Response in Hypertension

Journal of the American Heart Association, 2024-02, Vol.13 (4), p.e032433-e032433

2024

Volltextzugriff (PDF)

Two CES1 Gene Mutations Lead to Dysfunctional Carboxylesterase 1 Activity in Man: Clinical Significance and Molecular Basis

American journal of human genetics, 2008-06, Vol.82 (6), p.1241-1248

2008

Volltextzugriff (PDF)

Pharmacometabolomics reveals racial differences in response to atenolol treatment

PloS one, 2013-03, Vol.8 (3), p.e57639-e57639

2013

Volltextzugriff (PDF)

Warfarin pharmacogenetics: a rising tide for its clinical value

Circulation (New York, N.Y.), 2012-04, Vol.125 (16), p.1964-1966

Johnson, Julie A

2012

Volltextzugriff (PDF)

Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers

PloS one, 2019-09, Vol.14 (9), p.e0221957

2019

Volltextzugriff (PDF)

Pharmacogenomics of antihypertensive drugs: Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study

The American heart journal, 2009-03, Vol.157 (3), p.442-449

2009

Volltextzugriff (PDF)

Preserving the genetic integrity of human embryonic stem cells

Nature biotechnology, 2005-01, Vol.23 (1), p.19-20

2005

Volltextzugriff (PDF)

1 – 25 von 1.514

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.214)
Mit Volltextzugriff
(1.279)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.511)
Chinesisch
(2)
Deutsch
(2)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(959)
Life Sciences & Biomedicine
(889)
Humans
(762)
Female
(466)
Male
(429)
Middle Aged
(285)
Adult
(250)
Biological And Medical Sciences
(232)
Aged
(214)
Medical Sciences
(197)
Pharmacology & Pharmacy
(121)
General & Internal Medicine
(117)
Treatment Outcome
(112)
Cardiovascular System & Cardiology
(109)
Animals
(108)
Adolescent
(106)
Pharmacogenetics
(100)
Medicine, General & Internal
(99)
Genotype
(95)
Risk Factors
(94)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Zukunft Bildungschancen: Ergebnisse und Perspektiven aus Forschung und Praxis

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update

Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing

CYP2D6 pharmacogenetics and phenoconversion in personalized medicine

Pharmacogenetics in clinical practice: how far have we come and where are we going?

CYP2C19 Polymorphisms and Therapeutic Drug Monitoring of Voriconazole: Are We Ready for Clinical Implementation of Pharmacogenomics?

Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects

Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement

Individualized Placement and Support Supported Employment for Justice-involved Homeless and Unemployed Veterans

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

Comparison of Data Normalization Strategies for Array-Based MicroRNA Profiling Experiments and Identification and Validation of Circulating MicroRNAs as Endogenous Controls in Hypertension

Clinical pharmacogenetics implementation: Approaches, successes, and challenges

Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention

CYP4F2 genetic variant alters required warfarin dose

Ethnic Differences in Cardiovascular Drug Response : Potential Contribution of Pharmacogenetics

A novel simple method for determining CYP2D6 gene copy number and identifying allele(s) with duplication/multiplication

Institutional profile: University of Florida Health Personalized Medicine Program

Circulating microRNA Biomarkers of Thiazide Response in Hypertension

Two CES1 Gene Mutations Lead to Dysfunctional Carboxylesterase 1 Activity in Man: Clinical Significance and Molecular Basis

Pharmacometabolomics reveals racial differences in response to atenolol treatment

Warfarin pharmacogenetics: a rising tide for its clinical value

Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers

Pharmacogenomics of antihypertensive drugs: Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study

Preserving the genetic integrity of human embryonic stem cells

Suchergebnisse filtern